0001350102 --12-31 2022 Q1 false 0.0002 P20D 0.0002 0001350102 2022-01-01 2022-03-31 xbrli:shares 0001350102 2022-05-12 iso4217:USD 0001350102 2022-03-31 0001350102 2021-12-31 iso4217:USD xbrli:shares 0001350102 us-gaap:SeriesAPreferredStockMember 2022-03-31 0001350102 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001350102 us-gaap:ProductMember 2022-01-01 2022-03-31 0001350102 us-gaap:ProductMember 2021-01-01 2021-03-31 0001350102 asti:MilestoneAndEngineeringMember 2022-01-01 2022-03-31 0001350102 2021-01-01 2021-03-31 0001350102 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001350102 us-gaap:PreferredStockMember asti:SeriesOneAPreferredStockMember 2021-12-31 0001350102 us-gaap:CommonStockMember 2021-12-31 0001350102 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001350102 us-gaap:RetainedEarningsMember 2021-12-31 0001350102 us-gaap:PreferredStockMember asti:SeriesOneAPreferredStockMember asti:TubesolarAGMember 2022-01-01 2022-03-31 0001350102 us-gaap:CommonStockMember asti:TubesolarAGMember 2022-01-01 2022-03-31 0001350102 us-gaap:AdditionalPaidInCapitalMember asti:TubesolarAGMember 2022-01-01 2022-03-31 0001350102 us-gaap:PreferredStockMember asti:CrowdexConvertibleNoteMember asti:SeriesOneAPreferredStockMember 2022-01-01 2022-03-31 0001350102 us-gaap:CommonStockMember asti:CrowdexConvertibleNoteMember 2022-01-01 2022-03-31 0001350102 us-gaap:AdditionalPaidInCapitalMember asti:CrowdexConvertibleNoteMember 2022-01-01 2022-03-31 0001350102 us-gaap:CommonStockMember asti:BDOneInvestmentHoldingLLCMember 2022-01-01 2022-03-31 0001350102 us-gaap:AdditionalPaidInCapitalMember asti:BDOneInvestmentHoldingLLCMember 2022-01-01 2022-03-31 0001350102 asti:BDOneInvestmentHoldingLLCMember 2022-01-01 2022-03-31 0001350102 us-gaap:CommonStockMember asti:NanyangConvertibleNotesMember 2022-01-01 2022-03-31 0001350102 us-gaap:AdditionalPaidInCapitalMember asti:NanyangConvertibleNotesMember 2022-01-01 2022-03-31 0001350102 asti:NanyangConvertibleNotesMember 2022-01-01 2022-03-31 0001350102 us-gaap:CommonStockMember asti:FleurNoteMember 2022-01-01 2022-03-31 0001350102 us-gaap:AdditionalPaidInCapitalMember asti:FleurNoteMember 2022-01-01 2022-03-31 0001350102 asti:FleurNoteMember 2022-01-01 2022-03-31 0001350102 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001350102 us-gaap:OtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001350102 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-03-31 0001350102 us-gaap:CommonStockMember 2022-03-31 0001350102 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001350102 us-gaap:RetainedEarningsMember 2022-03-31 0001350102 us-gaap:OtherComprehensiveIncomeMember 2022-03-31 0001350102 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-12-31 0001350102 us-gaap:PreferredStockMember asti:SeriesOneAPreferredStockMember 2020-12-31 0001350102 us-gaap:CommonStockMember 2020-12-31 0001350102 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001350102 us-gaap:RetainedEarningsMember 2020-12-31 0001350102 2020-12-31 0001350102 us-gaap:PreferredStockMember asti:SeriesOneAPreferredStockMember 2021-01-01 2021-03-31 0001350102 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001350102 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001350102 us-gaap:CommonStockMember asti:GlobalIchibanConvertibleNotesMember 2021-01-01 2021-03-31 0001350102 us-gaap:AdditionalPaidInCapitalMember asti:GlobalIchibanConvertibleNotesMember 2021-01-01 2021-03-31 0001350102 asti:GlobalIchibanConvertibleNotesMember 2021-01-01 2021-03-31 0001350102 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001350102 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-03-31 0001350102 us-gaap:PreferredStockMember asti:SeriesOneAPreferredStockMember 2021-03-31 0001350102 us-gaap:CommonStockMember 2021-03-31 0001350102 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001350102 us-gaap:RetainedEarningsMember 2021-03-31 0001350102 2021-03-31 xbrli:pure 0001350102 2022-01-28 2022-01-28 0001350102 2022-01-28 0001350102 srt:MaximumMember 2022-01-28 2022-01-28 0001350102 srt:MinimumMember 2022-01-28 2022-01-28 0001350102 srt:MaximumMember 2022-01-28 0001350102 srt:MinimumMember 2022-01-28 0001350102 asti:MilestoneAndEngineeringArrangementMember 2022-01-01 2022-03-31 0001350102 asti:MilestoneAndEngineeringArrangementMember 2021-01-01 2021-03-31 0001350102 asti:GovernmentResearchAndDevelopmentMember 2022-01-01 2022-03-31 0001350102 asti:GovernmentResearchAndDevelopmentMember 2021-01-01 2021-03-31 0001350102 srt:ScenarioPreviouslyReportedMember 2022-03-31 0001350102 srt:ScenarioPreviouslyReportedMember 2021-12-31 0001350102 asti:TubesolarAGMember srt:MaximumMember asti:LongTermSupplyAndJointDevelopmentAgreementMember 2021-09-15 0001350102 asti:TubesolarAGMember asti:LongTermSupplyAndJointDevelopmentAgreementMember us-gaap:ProductMember 2022-03-31 0001350102 us-gaap:CoVenturerMember asti:JointVentureMember 2022-03-31 0001350102 asti:JointVentureMember 2022-01-01 2022-03-31 0001350102 us-gaap:FurnitureAndFixturesMember 2022-03-31 0001350102 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001350102 us-gaap:MachineryAndEquipmentMember 2022-03-31 0001350102 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001350102 asti:ManufacturingMachineryAndEquipmentInProgressMember 2022-03-31 0001350102 asti:ManufacturingMachineryAndEquipmentInProgressMember 2021-12-31 utr:sqft 0001350102 2020-09-21 0001350102 2020-09-20 2020-09-21 0001350102 2021-01-01 2021-01-01 0001350102 us-gaap:UnsecuredDebtMember asti:NotePayableConversionMember 2017-06-30 0001350102 us-gaap:UnsecuredDebtMember asti:NotePayableConversionMember 2022-01-01 2022-03-31 0001350102 asti:BD1ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2021-12-31 0001350102 asti:NanyangConvertibleNotesMember 2021-12-31 0001350102 asti:FleurNoteMember 2021-12-31 0001350102 asti:BD1ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2022-01-01 2022-03-31 0001350102 asti:NanyangConvertibleNotesMember 2022-01-01 2022-03-31 0001350102 asti:FleurNoteMember 2022-01-01 2022-03-31 0001350102 asti:BD1ConvertibleNotesMember us-gaap:ConvertibleDebtMember 2022-03-31 0001350102 asti:NanyangConvertibleNotesMember 2022-03-31 0001350102 asti:FleurNoteMember 2022-03-31 0001350102 asti:FleurMember asti:BD1ConvertibleNotesMember 2022-01-03 0001350102 asti:NanyangInvestmentManagementMember asti:BD1ConvertibleNotesMember 2022-01-21 0001350102 asti:BD1ConvertibleNotesMember 2022-01-21 0001350102 asti:BD1ConvertibleNotesMember 2022-02-01 0001350102 asti:BD1ConvertibleNotesMember 2022-01-31 2022-02-01 0001350102 asti:BDOneExchangeAgreementMember asti:NanyangInvestmentManagementMember asti:UnsecuredConvertibleNotesMember 2022-01-21 0001350102 asti:BDOneExchangeAgreementMember asti:NanyangInvestmentManagementMember asti:UnsecuredConvertibleNotesMember 2022-01-21 2022-01-21 0001350102 asti:BDOneExchangeAgreementMember asti:NanyangInvestmentManagementMember 2022-01-21 0001350102 asti:BDOneExchangeAgreementMember asti:NanyangInvestmentManagementMember 2022-01-21 2022-01-21 0001350102 asti:NanyangInvestmentManagementMember asti:UnsecuredConvertibleNotesMember 2022-02-02 0001350102 asti:NanyangInvestmentManagementMember 2022-02-02 2022-02-02 0001350102 asti:BDOneExchangeAgreementMember asti:FleurCapitalPteLtdMember asti:UnsecuredConvertibleNotesMember 2022-01-21 0001350102 asti:BDOneExchangeAgreementMember asti:FleurCapitalPteLtdMember asti:UnsecuredConvertibleNotesMember 2022-01-21 2022-01-21 0001350102 asti:BDOneExchangeAgreementMember asti:FleurCapitalPteLtdMember 2022-01-21 0001350102 asti:BDOneExchangeAgreementMember asti:FleurCapitalPteLtdMember 2022-01-21 2022-01-21 0001350102 asti:FleurCapitalPteLtdMember asti:UnsecuredConvertibleNotesMember 2022-02-02 0001350102 asti:FleurCapitalPteLtdMember 2022-02-02 2022-02-02 0001350102 us-gaap:SeriesAPreferredStockMember 2022-01-01 0001350102 us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-01-01 0001350102 us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-03-31 0001350102 us-gaap:CommonStockMember srt:MaximumMember 2022-03-31 0001350102 asti:SeriesOneAConvertiblePreferredStockMember asti:InitialClosingUnderSecuritiesPurchaseAgreementMember asti:CrowdexInvestmentsLimitedLiabilityCompanyMember 2022-01-01 0001350102 asti:SeriesOneAConvertiblePreferredStockMember asti:InitialClosingUnderSecuritiesPurchaseAgreementMember asti:TubesolarAGMember 2022-01-01 0001350102 asti:SeriesOneAConvertiblePreferredStockMember asti:InitialClosingUnderSecuritiesPurchaseAgreementMember 2022-01-01 0001350102 asti:SeriesOneAConvertiblePreferredStockMember asti:InitialClosingUnderSecuritiesPurchaseAgreementMember asti:CrowdexInvestmentsLimitedLiabilityCompanyMember 2022-01-31 2022-02-01 0001350102 asti:SeriesOneAConvertiblePreferredStockMember asti:InitialClosingUnderSecuritiesPurchaseAgreementMember asti:TubesolarAGMember 2022-01-31 2022-02-01 asti:vote 0001350102 asti:Series1APreferredStockMember 2022-03-31 0001350102 asti:SeriesB1PreferredStockMember 2022-03-31 0001350102 asti:SeriesB2PreferredStockMember 2022-03-31 0001350102 us-gaap:SeriesCPreferredStockMember 2022-03-31 0001350102 us-gaap:SeriesDPreferredStockMember 2022-03-31 0001350102 asti:SeriesD1PreferredStockMember 2022-03-31 0001350102 us-gaap:SeriesEPreferredStockMember 2022-03-31 0001350102 us-gaap:SeriesFPreferredStockMember 2022-03-31 0001350102 us-gaap:SeriesGPreferredStockMember 2022-03-31 0001350102 us-gaap:SeriesHPreferredStockMember 2022-03-31 0001350102 asti:SeriesIPreferredStockMember 2022-03-31 0001350102 asti:SeriesJPreferredStockMember 2022-03-31 0001350102 asti:SeriesJ1PreferredStockMember 2022-03-31 0001350102 asti:SeriesKPreferredStockMember 2022-03-31

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

 

 

 

 

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2022

or

 

 

 

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Transition Period from             to             

Commission File No. 001-32919

 

 

Ascent Solar Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

 

Delaware

 

20-3672603

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

 

 

12300 Grant Street, Thornton, CO

 

80241

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number including area code: 720-872-5000 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of exchange on which registered

Common

ASTI

OTC

 

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No    

Indicate by check mark whether the registrant has submitted every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).      Yes      No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer

 

  

Accelerated filer

 

 

 

 

 

 

 

 

Non-accelerated filer

 

  

Smaller reporting company

 

 

 

 

 

 

 

 

 

 

 

 

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

As of May 12, 2022, there were 30,586,804 shares of our common stock issued and outstanding.

 

 

 


 

 

ASCENT SOLAR TECHNOLOGIES, INC.

Quarterly Report on Form 10-Q

For the Period Ended March 31, 2022

Table of Contents

 

PART I. FINANCIAL INFORMATION

 

Item 1.

Unaudited Condensed Consolidated Financial Statements

1

 

Unaudited Condensed Consolidated Balance Sheets - as of March 31, 2022 and December 31, 2021

1

 

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income - For the Three Months Ended March 31, 2022 and 2021

2

 

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - for the Three Months Ended March 31, 2022 and 2021

3

 

Unaudited Condensed Consolidated Statements of Cash Flow - For the Three Months Ended March 31, 2022 and 2021

5

 

Notes to the Unaudited Condensed Consolidated Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

14

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

19

Item 4.

Controls and Procedures

19

PART II. OTHER INFORMATION

21

Item 1.

Legal Proceedings

21

Item 1A.

Risk Factors

21

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

21

Item 3.

Defaults Upon Senior Securities

21

Item 4.

Mine Safety Disclosures

21

Item 5.

Other Information

21

Item 6.

Exhibits

22

SIGNATURES

25

 

 

 

 


Table of Contents

 

 

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q includes “forward-looking statements” that involve risks and uncertainties. Forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events, future net sales or performance, capital expenditures, financing needs, plans or intentions relating to acquisitions, business trends and other information that is not historical information and, in particular, appear under headings including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business.” When used in this Quarterly Report, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “forecasts,” “foresees,” “likely,” “may,” “should,” “goal,” “target,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon information available to us on the date of this Quarterly Report.

These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements, including, among other things, the matters discussed in this Quarterly Report in the sections captioned “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Factors you should consider that could cause these differences are:

 

The impact of the novel coronavirus (“COVID-19”) pandemic on our business, results of operations, cash flows, financial condition and liquidity;

 

Our operating history and lack of profitability;

 

Our ability to develop demand for, and sales of, our products;

 

Our ability to attract and retain qualified personnel to implement our business plan and corporate growth strategies;

 

Our ability to develop sales, marketing and distribution capabilities;

 

Our ability to successfully develop and maintain strategic relationships with key partners, including OEMs, system integrators, distributors, and e-commerce companies, who deal directly with end users in our target markets;

 

The accuracy of our estimates and projections;

 

Our ability to secure additional financing to fund our short-term and long-term financial needs;

 

Our ability to maintain the listing of our common stock on the OTC Market;

 

The commencement, or outcome, of legal proceedings against us, or by us, including ongoing ligation proceedings;

 

Changes in our business plan or corporate strategies;

 

The extent to which we are able to manage the growth of our operations effectively, both domestically and abroad, whether directly owned or indirectly through licenses;

 

The supply, availability and price of equipment, components and raw materials, including the elements needed to produce our photovoltaic modules;

 

Our ability to expand and protect the intellectual property portfolio that relates to our consumer electronics, photovoltaic modules and processes;

 

Our ability to maintain effective internal controls over financial reporting;

 

Our ability to achieve projected operational performance and cost metrics;

 

General economic and business conditions, and in particular, conditions specific to consumer electronics and the solar power industry; and

 

Other risks and uncertainties discussed in greater detail elsewhere in this Quarterly Report and in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2021.

There may be other factors that could cause our actual results to differ materially from the results referred to in the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, or to reflect the occurrence of unanticipated events, except as required by law.

References to “we,” “us,” “our,” “Ascent,” “Ascent Solar” or the “Company” in this Quarterly Report mean Ascent Solar Technologies, Inc.

 

 


Table of Contents

ASCENT SOLAR TECHNOLOGIES, INC.

 

 

PART I. FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

 

 

 

March 31,

 

 

December 31,

 

 

 

2022

 

 

2021

 

ASSETS

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

3,028,362

 

 

$

5,961,760

 

Trade receivables, net of allowance of $26,000 and $26,000, respectively

 

 

561,254

 

 

 

49,250

 

Inventories, net

 

 

637,620

 

 

 

592,172

 

Prepaid and other current assets

 

 

659,538

 

 

 

247,736

 

Total current assets

 

 

4,886,774

 

 

 

6,850,918

 

 

 

 

 

 

 

 

 

 

Property, Plant and Equipment:

 

 

22,483,386

 

 

 

22,425,935

 

Accumulated depreciation

 

 

(22,158,146

)

 

 

(22,146,273

)

Property, Plant and Equipment, net

 

 

325,240

 

 

 

279,662

 

 

 

 

 

 

 

 

 

 

Other Assets:

 

 

 

 

 

 

 

 

Operating lease right-of-use assets, net

 

 

4,816,017

 

 

 

4,984,688

 

Patents, net of accumulated amortization of $139,842 and $135,050

   respectively

 

 

82,111

 

 

 

86,595

 

Equity method investment

 

 

97,665

 

 

 

21,205

 

Other non-current assets

 

 

625,000

 

 

 

625,000

 

Total Assets

 

$

10,832,807

 

 

$

12,848,068

 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

600,600

 

 

$

642,165

 

Related party payables

 

 

45,000

 

 

 

45,000

 

Accrued expenses

 

 

1,395,350

 

 

 

991,534

 

Accrued interest

 

 

490,778

 

 

 

475,671

 

Notes payable

 

 

250,000

 

 

 

250,000

 

Current portion of operating lease liability

 

 

665,585

 

 

 

646,742

 

Total current liabilities

 

 

3,447,313

 

 

 

3,051,112

 

Long-Term Liabilities:

 

 

 

 

 

 

 

 

Non-current operating lease liabilities

 

 

4,356,168

 

 

 

4,532,490

 

Non-current convertible notes, net

 

 

946,053

 

 

 

8,076,847

 

Accrued warranty liability

 

 

21,225

 

 

 

21,225

 

Total liabilities

 

 

8,770,759

 

 

 

15,681,674

 

Stockholders’ Equity (Deficit):

 

 

 

 

 

 

 

 

Series A preferred stock, $.0001 par value; 750,000 shares authorized; 48,100

   and 48,100 shares issued and outstanding, respectively ($813,558 and

$801,533 Liquidation Preference, respectively)

 

 

5

 

 

 

5

 

Common stock, $0.0001 par value, 500,000,000 authorized; 30,586,804

   and 4,786,804 shares issued and outstanding, respectively

 

 

3,059

 

 

 

479

 

Additional paid in capital

 

 

434,146,118

 

 

 

424,948,698

 

Accumulated deficit

 

 

(432,080,037

)

 

 

(427,782,788

)

Accumulated other comprehensive loss

 

 

(7,097

)

 

 

-

 

Total stockholders’ equity (deficit)

 

 

2,062,048

 

 

 

(2,833,606

)

Total Liabilities and Stockholders’ Equity (Deficit)

 

$

10,832,807

 

 

$

12,848,068

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

1


Table of Contents

ASCENT SOLAR TECHNOLOGIES, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(unaudited)

 

 

Three Months Ended

March 31,

 

 

2022

 

 

 

 

2021

 

Revenues

 

 

 

 

 

 

 

 

 

Products

$

54,210

 

 

 

 

$

165,158

 

Milestone and engineering

 

512,000

 

 

 

 

 

-

 

Total Revenues

 

566,210

 

 

 

 

 

165,158

 

Costs and Expenses

 

 

 

 

 

 

 

 

 

Costs of revenue

 

532,890

 

 

 

 

 

72,782

 

Research, development and manufacturing operations

 

1,406,322

 

 

 

 

 

728,036

 

Selling, general and administrative

 

821,266

 

 

 

 

 

561,709

 

Depreciation and amortization

 

16,665

 

 

 

 

 

12,872

 

Total Costs and Expenses

 

2,777,143

 

 

 

 

 

1,375,399

 

Loss from Operations

 

(2,210,933

)

 

 

 

 

(1,210,241

)

Other Income/(Expense)

 

 

 

 

 

 

 

 

 

Other income/(expense), net

 

-

 

 

 

 

 

800

 

Interest expense

 

(2,086,314

)

 

 

 

 

(562,079

)

Change in fair value of derivatives and

   gain/(loss) on extinguishment of

   liabilities, net

 

-

 

 

 

 

 

3,617,904

 

Total Other Income/(Expense)

 

(2,086,314

)

 

 

 

 

3,056,625

 

Income/(Loss) on Equity Method Investments

 

(2

)

 

 

 

 

-

 

Net Income/(Loss)

$

(4,297,249

)

 

 

 

$

1,846,384

 

Net Income/(Loss) Per Share (Basic)

$

(0.20

)

 

 

 

$

0.51

 

Net Income/(Loss) Per Share (Diluted)

$

(0.20

)

 

 

 

$

0.05

 

Weighted Average Common Shares

   Outstanding (Basic)

 

21,671,248

 

 

 

 

 

3,633,730

 

Weighted Average Common Shares

   Outstanding (Diluted)

 

21,671,248

 

 

 

 

 

32,511,508

 

Other Comprehensive Income/(Loss)

 

 

 

 

 

 

 

 

 

Foreign currency translation gain/(loss)

 

(7,097

)

 

 

 

 

-

 

Net Comprehensive Income/(Loss)

$

(4,304,346

)

 

 

 

$

1,846,384

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

2


Table of Contents

ASCENT SOLAR TECHNOLOGIES, INC.

 

 

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(unaudited)

For the Three Months Ended March 31, 2022

 

 

 

Series A

Preferred Stock

 

 

Series 1A

Preferred Stock

 

 

Common Stock

 

 

Additional

Paid-In

 

 

Accumulated

 

 

Other Comprehensive

 

 

Total

Stockholders’

Equity

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Loss

 

 

(Deficit)

 

Balance at January 1,

   2022

 

 

48,100

 

 

$

5

 

 

 

3,700

 

 

$

-

 

 

 

4,786,804

 

 

$

479

 

 

$

424,948,698

 

 

$

(427,782,788

)

 

 

 

 

 

$

(2,833,606

)

Conversion of TubeSolar Series 1A

   Preferred Stock into Common

   Stock

 

 

-

 

 

 

-

 

 

 

(2,400

)

 

 

-

 

 

 

4,800,000

 

 

 

480

 

 

 

(480

)

 

 

-

 

 

 

-

 

 

 

-

 

Conversion of Crowdex Series 1A

   Preferred Stock into Common

   Stock

 

 

-

 

 

 

-

 

 

 

(1,300

)

 

 

-

 

 

 

2,600,000

 

 

 

260

 

 

 

(260

)

 

 

-

 

 

 

-

 

 

 

-

 

Conversion of BD1 Note

   into Common Stock

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

15,800,000

 

 

 

1,580

 

 

 

7,898,420

 

 

 

-

 

 

 

-

 

 

 

7,900,000

 

Conversion of Nanyang Note

   into Common Stock

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,200,000

 

 

 

120

 

 

 

599,880

 

 

 

-

 

 

 

-

 

 

 

600,000

 

Conversion of Fleur Note into

   Common Stock

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,400,000

 

 

 

140

 

 

 

699,860

 

 

 

-

 

 

 

-

 

 

 

700,000

 

Net Income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,297,249

)

 

 

-

 

 

 

(4,297,249

)

Foreign currency translation

   gain/(loss)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(7,097

)

 

 

(7,097

)

Balance at March 31,

   2022

 

 

48,100

 

 

$

5

 

 

 

-

 

 

$

-

 

 

 

30,586,804

 

 

$

3,059

 

 

$

434,146,118

 

 

$

(432,080,037

)

 

$

(7,097

)

 

$

2,062,048

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3


Table of Contents

ASCENT SOLAR TECHNOLOGIES, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(unaudited)

For the Three Months Ended March 31, 2021

 

 

 

Series A

Preferred Stock

 

 

Series 1A

Preferred Stock

 

 

Common Stock

 

 

Additional

Paid-In

 

 

Accumulated

 

 

Total

Stockholders’

Equity

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

(Deficit)

 

Balance at January 1,

   2021

 

 

48,100

 

 

$

5

 

 

 

1,300

 

 

$

-

 

 

 

3,659,828

 

 

$

366

 

 

$

401,590,211

 

 

$

(421,782,785

)

 

$

(20,192,203

)

Proceeds from issuance of

   Series 1A Preferred

   Stock

 

 

-

 

 

 

-

 

 

 

2,500

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,500,000

 

 

 

-

 

 

 

2,500,000

 

Proceeds from issuance of

   Common Stock

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,500

 

 

 

2

 

 

 

2,999,998

 

 

 

-

 

 

 

3,000,000

 

Conversion of Global

   Ichiban Note into

   Common Shares

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

33,600

 

 

 

3

 

 

 

5,799,997

 

 

 

-

 

 

 

5,800,000

 

Relieved on Conversion of

   Derivative Liability

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,686,079

 

 

 

-

 

 

 

1,686,079

 

Net Income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,846,384

 

 

 

1,846,384

 

Balance at March 31,

   2021

 

 

48,100

 

 

$

5

 

 

 

3,800

 

 

$

-

 

 

 

3,694,928

 

 

$

371

 

 

$

414,576,285

 

 

$

(419,936,401

)

 

$

(5,359,740

)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4


Table of Contents

ASCENT SOLAR TECHNOLOGIES, INC.

 

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

 

 

For the Three Months Ended

 

 

 

March 31,

 

 

 

2022

 

 

2021

 

Operating Activities:

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(4,297,249

)

 

$

1,846,384

 

Adjustments to reconcile net income (loss) to cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

16,665

 

 

 

12,874

 

Operating lease asset amortization

 

 

168,671

 

 

 

158,502

 

Amortization of debt discount

 

 

2,069,206

 

 

 

542,164

 

Loss on equity method investment

 

 

2

 

 

 

 

Warranty reserve

 

 

 

 

 

(463

)

Gain on extinguishment of liabilities, net

 

 

 

 

 

(3,617,904

)

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(512,004

)

 

 

(12,100

)

Inventories

 

 

(45,448

)

 

 

(130,369

)

Prepaid expenses and other current assets

 

 

(411,802

)

 

 

(161,592

)

Accounts payable

 

 

(41,565

)

 

 

(96,691

)

Related party payable

 

 

 

 

 

(103,334

)

Operating lease liabilities

 

 

(157,479

)

 

 

(140,105

)

Accrued interest

 

 

15,107

 

 

 

5,413

 

Accrued expenses

 

 

403,816

 

 

 

(312,073

)

Net cash used in operating activities

 

 

(2,792,080

)

 

 

(2,009,294

)

Investing Activities:

 

 

 

 

 

 

 

 

Contributions to equity method investment

 

 

(83,559

)

 

 

 

Payments on purchase of assets

 

 

(57,451

)

 

 

 

Patent activity costs

 

 

(308

)

 

 

 

Net cash used in investing activities

 

 

(141,318

)

 

 

 

Financing Activities:

 

 

 

 

 

 

 

 

Proceeds from issuance of stock

 

 

 

 

 

5,500,000

 

Net cash provided by financing activities

 

 

 

 

 

5,500,000

 

Net change in cash and cash equivalents

 

 

(2,933,398

)

 

 

3,490,706

 

Cash and cash equivalents at beginning of period

 

 

5,961,760

 

 

 

167,725

 

Cash and cash equivalents at end of period

 

$

3,028,362

 

 

$

3,658,431

 

Non-Cash Transactions:

 

 

 

 

 

 

 

 

Non-cash conversions of preferred stock and convertible notes to equity

 

$

9,200,000

 

 

$

5,800,000

 

Series 1A preferred stock conversion

 

$

740

 

 

$

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5


Table of Contents

 

 

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1. ORGANIZATION

Ascent Solar Technologies, Inc. and its wholly owned subsidiary, Ascent Solar (Asia) Pte. Ltd. (collectively, the “Company") is focusing on integrating its PV products into high value markets such as aerospace, satellites, near earth orbiting vehicles, and fixed wing unmanned aerial vehicles (“UAV”). The value proposition of Ascent’s proprietary solar technology not only aligns with the needs of customers in these industries, but also overcomes many of the obstacles other solar technologies face in these unique markets. Ascent has the capability to design and develop finished products for end users in these areas as well as collaborate with strategic partners to design and develop custom integrated solutions for products like fixed-wing UAVs. Ascent sees significant overlap of the needs of end users across some of these industries and can achieve economies of scale in sourcing, development, and production in commercializing products for these customers.

On January 28, 2022 as of 5:00 pm Eastern Time, the Company effected a reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) at a ratio of one-for-five thousand (the “Reverse Stock Split”). The Company’s common stock began trading on a split-adjusted basis at 9:30 am Eastern Time on January 31, 2022. Stockholders also received one whole share of Common Stock in lieu of a fractional share and no fractional shares were issued. All shares and per share amounts in the condensed consolidated financial statements and accompanying notes have been retroactively adjusted to give effect to the Reverse Stock Split.

 

Following the Reverse Stock Split, the Company’s issued and outstanding shares of Common Stock were decreased from approximately 23.7 billion pre-split shares to 4.8 million post-split shares. In connection with the Reverse Stock Split effectiveness, the number of authorized shares of the Company's Common Stock were decreased from 30 billion to 500 million shares.

NOTE 2. BASIS OF PRESENTATION

The accompanying, unaudited, condensed consolidated financial statements have been derived from the accounting records of the Company as of March 31, 2022 and December 31, 2021, and the results of operations for the three months ended March 31, 2022 and 2021. All significant inter-company balances and transactions have been eliminated in the accompanying condensed consolidated financial statements.

The accompanying, unaudited, condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, these interim financial statements do not include all of the information and footnotes typically found in U.S. GAAP audited annual financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement have been included. The Condensed Consolidated Balance Sheet at December 31, 2021 has been derived from the audited financial statements as of that date but does not include all of the information and footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. These condensed consolidated financial statements and notes should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022.

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The Company’s significant accounting policies were described in Note 3 to the audited financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. There have been no significant changes to our accounting policies as of March 31, 2022.

6


Table of Contents

 

Revenue Recognition:

Product revenue. The Company recognizes revenue for the sale of PV modules and other equipment sales at a point in time following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts. For module and other equipment sales contracts that contain multiple performance obligations, the Company allocates the transaction price to each performance obligation identified in the contract based on relative standalone selling prices, or estimates of such prices, and recognizes the related revenue as control of each individual product is transferred to the customer.

During the three months ended March 31, 2022 and 2021, the Company recognized product revenue of $54,210 and $165,158, respectively.

Milestone and engineering revenue. Each milestone and engineering arrangement is a separate performance obligation. The transaction price is estimated using the most likely amount method and revenue is recognized as the performance obligation is satisfied through achieving manufacturing, cost, or engineering targets. During the three months ended March 31, 2022, the Company recognized Milestone and engineering revenue of $512,000 from TubeSolar AG (“TubeSolar”), a significant existing stakeholder in the Company and a related party. The Company did not have Milestone and engineering revenue during the three months ended March 31, 2021.

Government contracts revenue. Revenue from government research and development contracts is generated under terms that are cost plus fee or firm fixed price. The Company generally recognizes this revenue over time using cost-based input methods, which recognizes revenue and gross profit as work is performed based on the relationship between actual costs incurred compared to the total estimated costs of the contract. In applying cost-based input methods of revenue recognition, the Company uses the actual costs incurred relative to the total estimated costs to determine our progress towards contract completion and to calculate the corresponding amount of revenue to recognize.

Cost based input methods of revenue recognition are considered a faithful depiction of the Company’s efforts to satisfy long-term government research and development contracts and therefore reflect the performance obligations under such contracts. Costs incurred that do not contribute to satisfying the Company’s performance obligations are excluded from the input methods of revenue recognition as the amounts are not reflective of transferring control under the contract. Costs incurred towards contract completion may include direct costs plus allowable indirect costs and an allocable portion of the fixed fee. If actual and estimated costs to complete a contract indicate a loss, provision is made currently for the loss anticipated on the contract.

No government contract revenue was recognized during the three months ended March 31, 2022 and 2021.

As of March 31, 2022 and December 31, 2021, the Company had an accounts receivable, net balance of $561,254 and $49,250, respectively. As of March 31, 2022 and December 31, 2021, the Company had an allowance for doubtful accounts of $26,000 and $26,000, respectively.

Deferred revenue was as follows:    

 

Balance as of January 1, 2022

$

22,500

 

Additions

 

198,500

 

Recognized as revenue

 

(22,500

)

Balance as of March 31, 2022

$

198,500

 

Earnings per Share: Earnings per share (“EPS”) are the amount of earnings attributable to each share of common stock. Basic EPS has been computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding during the period. Income available to common stockholders has been computed by deducting dividends accumulated for the period on cumulative preferred stock (whether or not earned) from net income. Diluted earnings per share has been computed by dividing net income adjusted on an if-converted basis for the period by the weighted average number of common shares and potentially dilutive common share outstanding (which consist of options and convertible securities using the treasury stock method or the if-converted method, as applicable, to the extent they are dilutive). Approximately 2.4 million shares of dilutive shares were excluded from the three months period ended March 31, 2022 EPS calculation as their impact is antidilutive. There were approximately 32.5 million shares of dilutive shares for the three months period ended March 31, 2021.  

7


Table of Contents

 

Recently Adopted or to be Adopted Accounting Policies

In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging Contracts in Entity s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity s Own Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being separately recognized from the host contract as compared with current U.S. GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06 will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Management has not yet evaluated the impact that the adoption of ASU 2020-06 will have on the Company’s condensed consolidated financial statement presentation or disclosures.

Other new pronouncements issued but not effective as of March 31, 2022 are not expected to have a material impact on the Company’s condensed consolidated financial statements.

NOTE 4. LIQUIDITY, CONTINUED OPERATIONS, AND GOING CONCERN    

During the year ended December 31, 2021, the Company entered into multiple financing agreements to fund operations. Further discussion of these transactions can be found in Notes 8, 9, 10, and 11 in the Company's Annual Report on Form 10-K for the year ended December 31, 2021.

The Company has continued limited PV production at its manufacturing facility. The Company does not expect that sales revenue and cash flows will be sufficient to support operations and cash requirements until it has fully implemented its product strategy. During the three months ended March 31, 2022 the Company used $2,792,080 in cash for operations.

Additional projected product revenues are not anticipated to result in a positive cash flow position for the next twelve months overall and, as of March 31, 2022, the Company has working capital of $1,439,461. As such, cash liquidity is not sufficient for the next twelve months and will require additional financing.

The Company continues to accelerate sales and marketing efforts related to its consumer and military solar products and specialty PV application strategies through expansion of its sales and distribution channels. The Company continues activities related to securing additional financing through strategic or financial investors, but there is no assurance the Company will be able to raise additional capital on acceptable terms or at all. If the Company's revenues do not increase rapidly, and/or additional financing is not obtained, the Company will be required to significantly curtail operations to reduce costs and/or sell assets. Such actions would likely have an adverse impact on the Company's future operations.

As a result of the Company’s recurring losses from operations and the need for additional financing to fund its operating and capital requirements, there is uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises doubt as to the Company’s ability to continue as a going concern.

Management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. These condensed consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.

NOTE 5. RELATED PARTY TRANSACTIONS

On September 15, 2021, the Company entered into a Long-Term Supply and Joint Development Agreement (“JDA”) with TubeSolar AG (“TubeSolar”). Under the terms of the JDA, the Company will produce, and TubeSolar will purchase, thin-film photovoltaic (“PV”) foils (“PV Foils”) for use in TubeSolar’s solar modules for agricultural photovoltaic (“APV”) applications that require solar foils for its production. Additionally, the Company will receive up (i) to $4 million of non-recurring engineering (“NRE”) fees, and (ii) up to $13.5 million of payments upon achievement of certain agreed production and cost

8


Table of Contents

 

structure milestones. The JDA has no fixed term, and may only be terminated by either party for breach. $500,000 of NRE revenue was recognized under the JDA during the three months ended March 31, 2022.

The Company and TubeSolar have also jointly established Ascent Solar Technologies Germany GmbH (“Ascent Germany”), in which TubeSolar holds of 30% of the entity. The purpose of Ascent Germany is to establish and operate a PV manufacturing facility in Germany that will produce and deliver PV Foils exclusively to TubeSolar. Until Ascent Germany’s facility is fully operational, PV Foils will be manufactured in the Company’s existing facility in Thornton, Colorado. The parties expect to jointly develop next generation tooling for use in manufacturing PV Foils at the JV facility. The Company accounts for this investment as an equity method investment as it does not have control of this entity, but does have significant influence over the activities that most significantly impacts the entity’s operations and financial performance. The Company contributed $83,559 to Ascent Germany during the three months ended March 31, 2022. The Company currently cannot quantify its maximum exposure in this entity.

NOTE 6. PROPERTY, PLANT AND EQUIPMENT

The following table summarizes property, plant and equipment as of March 31, 2022 and December 31, 2021:

 

 

 

As of

March 31,

 

 

As of

December 31,

 

 

 

2022

 

 

2021

 

Furniture, fixtures, computer hardware and

   computer software

 

$

494,897

 

 

$

473,448

 

Manufacturing machinery and equipment

 

 

21,867,097

 

 

 

21,863,624

 

Manufacturing machinery and equipment,

   in progress

 

 

121,392

 

 

 

88,863

 

Depreciable property, plant and equipment

 

 

22,483,386

 

 

 

22,425,935

 

Less: Accumulated depreciation and amortization

 

 

(22,158,146

)

 

 

(22,146,273

)

Net property, plant and equipment

 

$

325,240

 

 

$

279,662

 

 

Depreciation expense for the three months ended March 31, 2022 and 2021 was $11,873 and $2,724, respectively.   Depreciation expense is recorded under “Depreciation and amortization expense” in the unaudited Condensed Consolidated Statements of Operations.

NOTE 7. OPERATING LEASE

The Company leases approximately 100,000 rentable square feet for its manufacturing and operations. The lease is classified as an operating lease and accounted for accordingly. The Lease term is for 88 months commencing on September 21, 2020 at a rent of $50,000 per month including taxes, insurance and common area maintenance until December 31, 2020. Beginning January 1, 2021, the rent adjusted to $80,000 per month on a triple net basis and shall increase at an annual rate of 3% per annum until December 31, 2027.

As of March 31, 2022 and December 31, 2021, assets and liabilities related to the Company’s lease were as follows:

 

 

 

As of

March 31,

 

 

As of

December 31,

 

 

 

2022

 

 

2021

 

Operating lease right-of-use assets, net

 

$

4,816,017

 

 

$

4,984,688

 

Current portion of operating lease liability

 

 

665,585

 

 

 

646,742

 

Non-current portion of operating lease liability

 

 

4,356,168

 

 

 

4,532,490

 

During the three months ended March 31, 2022 and 2021 the Company recorded operating lease costs included in rent expense of $258,392 and $258,393, respectively.

9


Table of Contents

 

Future maturities of the operating lease liability are as follows:

 

Remainder of 2022

 

$

741,600

 

2023

 

 

1,018,464

 

2024

 

 

1,049,018

 

2025

 

 

1,080,488

 

2026

 

 

1,112,903

 

Thereafter

 

 

1,146,290

 

Total lease payments

 

 

6,148,763

 

Less amounts representing interest

 

 

(1,127,010

)

Present value of lease liability

 

$

5,021,753

 

 

The remaining lease term and discount rate of the operating lease is 69.5 months and 7.0%, respectively.

 

NOTE 8. INVENTORIES

Inventories, net of reserves, consisted of the following at March 31, 2022 and December 31, 2021:

 

 

 

As of

March 31,

 

 

As of

December 31,

 

 

 

2022

 

 

2021

 

Raw materials

 

$

592,300

 

 

$

575,154

 

Work in process

 

 

41,619

 

 

 

15,803

 

Finished goods

 

 

3,700

 

 

 

1,215

 

Total

 

$

637,620

 

 

$

592,172

 

 

NOTE 9. NOTES PAYABLE

On June 30, 2017, the Company entered into an agreement with a vendor (“Vendor”) to convert the balance of their account into a note payable in the amount of $250,000. The note bears interest of 5% per annum and matured on February 28, 2018. As of March 31, 2022, the Company had not made any payments on this note, the accrued interest was $59,418, and the note is due upon demand. To the best of our knowledge, Vendor has not made any attempts to recover any amount owing to them since 2019.

 

NOTE 10. CONVERTIBLE NOTES

The following table provides a summary of the activity of the Company's unsecured, convertible, promissory notes:

 

 

Principal

Balance

1/1/2022

 

New

Notes

 

Notes assigned or exchanged

 

Notes

converted

 

Principal

Balance

3/31/2022

 

Less:

Discount

Balance

 

Net

Principal

Balance

3/31/2022

 

BD1 Notes

  (related party)

$

9,900,000

 

$

 

$

(2,000,000

)

$

(7,900,000

)

$

 

$

 

$

 

Nanyang Note

 

500,000

 

 

 

 

1,000,000

 

 

(600,000

)

 

900,000

 

 

(190,442

)

 

709,558

 

Fleur Note

 

 

 

 

 

1,000,000

 

 

(700,000

)

 

300,000

 

 

(63,505

)

 

236,495

 

 

$

10,400,000

 

$

 

$

 

$

(9,200,000

)

$

1,200,000

 

$

(253,947

)

$

946,053

 

 

BD1 Convertible Note

On January 3, 2022, BD 1 Investment Holding, LLC (“BD1”) sold and assigned $1,000,000 of its convertible notes (“BD1 Convertible Notes”) to Fleur Capital Pte Ltd (“Fleur”). On January 21, 2022, BD1 sold and assigned $1,000,000 of its convertible notes to Nanyang Investment Management Pte Ltd (“Nanyang”). The aggregate remaining principal balance held by BD1 after these assignments was $7,900,000. On February 1, 2022, BD1 converted its $7,900,000 aggregate outstanding

10


Table of Contents

 

principal amount into 15,800,000 shares of common stock. The remaining discount of approximately $1,721,000 was charged to interest expense upon conversion.  

Nanyang Convertible Note

On January 21, 2022, as discussed above, BD1 assigned $1,000,000 of the BD1 Convertible Notes to Nanyang. This note does not bear any interest and will mature on December 18, 2025. Nanyang has the right, at any time until the note is fully paid, to convert any outstanding and unpaid principal into share of common stock at a fixed conversion price equal to $0.50 per share. Shares of common stock may not be issued pursuant to this note if, after giving effect to the conversion or issuance, Nanyang, together with its affiliates, would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock.  

On February 2, 2022, Nanyang converted $600,000 of their convertible notes into 1,200,000 shares of common stock. The associated discount on the converted portion of the notes of approximately $133,000 was charged to interest expense. The discount on the remaining principal will be charged to interest expense, ratably, over the life of the note.

Fleur Convertible Note

On January 21, 2022, as discussed above, BD1 assigned $1,000,000 of the BD1 Convertible Notes to Fleur. This note does not bear any interest and will mature on December 18, 2025. Fleur has the right, at any time until the note is fully paid, to convert any outstanding and unpaid principal into share of common stock at a fixed conversion price equal to $0.50 per share. Shares of common stock may not be issued pursuant to this note if, after giving effect to the conversion or issuance, Fleur, together with its affiliates, would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock.  

On February 2, 2022, Fleur converted $700,000 of their convertible notes into 1,400,000 shares of common stock. The associated discount on the converted portion of the notes of approximately $155,000 was charged to interest expense. The discount on the remaining principal will be charged to interest expense, ratably, over the life of the note.

NOTE 11. SERIES A PREFERRED STOCK

As of January 1, 2022, there were 48,100 shares of Series A Preferred Stock outstanding. Holders of Series A Preferred Stock are entitled to cumulative dividends at a rate of 8% per annum when and if declared by the Board of Directors in its sole discretion. The dividends may be paid in cash or in the form of common stock (valued at 10% below market price, but not to exceed the lowest closing price during the applicable measurement period), at the discretion of the Board of Directors. The dividend rate on the Series A Preferred Stock is indexed to the Company's stock price and subject to adjustment. In addition, the Series A Preferred Stock contains a make-whole provision whereby, conversion or redemption of the preferred stock within 4 years of issuance will require dividends for the full four year period to be paid by the Company in cash or common stock (valued at 10% below market price, but not to exceed the lowest closing price during the applicable measurement period). This make-whole provision expired in June 2017.

The Series A Preferred Stock may be converted into shares of common stock at the option of the Company if the closing price of the common stock exceeds $1,160,000, as adjusted, for twenty consecutive trading days, or by the holder at any time. The Company has the right to redeem the Series A Preferred Stock at a price of $8.00 per share, plus any accrued and unpaid dividends, plus the make-whole amount (if applicable). At March 31, 2022, the preferred shares were not eligible for conversion to common shares at the option of the Company. The holder of the preferred shares may convert to common shares at any time. After making adjustment for the Company’s prior reverse stock splits, all 48,100 outstanding Series A preferred shares are convertible into less than one common share. Upon any conversion (whether at the option of the Company or the holder), the holder is entitled to receive any accrued but unpaid dividends.

Except as otherwise required by law (or with respect to approval of certain actions), the Series A Preferred Stock shall have no voting rights. Upon any liquidation, dissolution or winding up of the Company, after payment or provision for payment of debts and other liabilities of the Company, the holders of Series A Preferred Stock shall be entitled to receive, pari passu with any distribution to the holders of common stock of the Company, an amount equal to $8.00 per share of Series A Preferred Stock plus any accrued and unpaid dividends.

As of March 31, 2022, there were 48,100 shares of Series A Preferred Stock outstanding and accrued and unpaid dividends of $428,758.

11


Table of Contents

 

NOTE 12. SERIES 1A PREFERRED STOCK

Series 1A Preferred Stock – Tranche 1 Closing

As of January 1, 2022, there were 3,700 shares of Series 1A Preferred Stock outstanding; 1,300 shares owned by Crowdex Investment, LLC (“Crowdex”) and 2,400 shares owned by TubeSolar. Each share of Series 1A Preferred Stock has an original issue price of $1,000 per share. Shares of the Series 1A Preferred Stock are convertible into common stock at a fixed conversion price equal to $0.50 per common share, subject to standard ratable anti-dilution adjustments.

Outstanding shares of Series 1A Preferred Stock are entitled to vote together with the holders of common stock as a single class (on an as-converted to common stock basis) on any matter presented to the stockholders of the Company for their action or consideration at any meeting of stock holders (or written consent of stockholders in lieu of meeting).

Holders of the Series 1A Preferred Stock are not entitled to any fixed rate of dividends. If the Company pays a dividend or otherwise makes a distribution payable on shares of common stock, holders of the Series 1A Preferred Stock will receive such dividend or distribution on an as-converted to common stock basis. There are no specified redemption rights for the Series 1A Preferred Stock. Upon liquidation, dissolution or winding up, holders of Series 1A Preferred Stock will be entitled to be paid out of our assets, prior to the holders of our common stock, an amount equal to $1,000 per share plus any accrued but unpaid dividends (if any) thereon.

On February 1, 2022 Crowdex and TubesSolar converted their remaining shares 1,300 and 2,400, respectively, of Series 1A Preferred Stock into 2,600,000 and 4,800,000, respectively shares of common stock.

 

NOTE 13. STOCKHOLDERS’ EQUITY (DEFICIT)

Common Stock

At March 31, 2022, the Company had 500 million shares of common stock, $0.0001 par value, authorized for issuance. Each share of common stock has the right to one vote. As of March 31, 2022, the Company had 30,586,804 shares of common stock outstanding. The Company has not declared or paid any dividends related to the common stock through March 31, 2022.

Preferred Stock

At March 31, 2022, the Company had 25 million shares of preferred stock, $0.0001 par value, authorized for issuance. Preferred stock may be issued in classes or series. Designations, powers, preferences, rights, qualifications, limitations and restrictions are determined by the Company’s Board of Directors. 

12


Table of Contents

 

The following table summarizes the designations, shares authorized, and shares outstanding for the Company's Preferred Stock:

 

Preferred Stock Series Designation

 

Shares

Authorized

 

 

Shares

Outstanding

 

Series A

 

 

750,000

 

 

 

48,100

 

Series 1A

 

 

5,000

 

 

 

 

Series B-1

 

 

2,000

 

 

 

 

Series B-2

 

 

1,000

 

 

 

 

Series C

 

 

1,000

 

 

 

 

Series D

 

 

3,000

 

 

 

 

Series D-1

 

 

2,500

 

 

 

 

Series E

 

 

2,800

 

 

 

 

Series F

 

 

7,000

 

 

 

 

Series G

 

 

2,000

 

 

 

 

Series H

 

 

2,500

 

 

 

 

Series I

 

 

1,000

 

 

 

 

Series J

 

 

1,350

 

 

 

 

Series J-1

 

 

1,000

 

 

 

 

Series K

 

 

20,000

 

 

 

 

 

Series A Preferred Stock

Refer to Note 11 for Series A Preferred Stock activity.

 

Series 1A Preferred Stock

Refer to Note 12 for Series 1A Preferred Stock activity.

Series B-1, B-2, C, D, D-1, E, F, G, H, I, J, J-1, and K Preferred Stock

There were no transactions involving the Series B-1, B-2, C, D, D-1, E, F, G, H, I, J, J-1, or K during the three months ended March 31, 2022 and 2021.

NOTE 14. SUBSEQUENT EVENTS

There were no events subsequent to March 31, 2022 to report as of this filing on May 12, 2022.

 

13


Table of Contents

 

 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations should be read in conjunction with our unaudited financial statements and the notes to those financial statements appearing elsewhere in this Form 10-Q and our audited financial statements and related notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC on March 14, 2022. This discussion and analysis contains statements of a forward-looking nature relating to future events or our future financial performance. As a result of many factors, our actual results may differ materially from those anticipated in these forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should carefully read the “Risk Factors” section of this Quarterly Report and of our Annual Report on Form 10-K for the year ended December 31, 2021 to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements. Please also see the section entitles “Forward-Looking Statements.”

Overview

We target high-value specialty solar markets. These include aerospace, defense, emergency management and consumer/OEM applications. This strategy enables us to fully leverage what we believe are the unique advantages of our technology, including flexibility, durability and attractive power to weight and power to area performance. It further enables us to offer unique, differentiated solutions in large markets with less competition, and more attractive pricing.

Specifically, we focus on commercializing our proprietary solar technology in three highest-value PV verticals:

I. Aerospace: Space, Near-space and Fixed Wing UAV

II. Public Sector: Defense and Emergency Management

III. Commercial Off-grid and Portable Power

We believe the value proposition of Ascent’s proprietary solar technology not only aligns with the needs of customers in these verticals, but also overcomes many of the obstacles other solar technologies face in these unique markets. Ascent has the capability to design and develop finished products for end users in these areas as well as collaborate with strategic partners to design and develop custom integrated solutions for products like airships and fixed-wing UAVs. Ascent sees significant overlap in the needs of end users across some of these verticals and believes it can achieve economies of scale in sourcing, development, and production in commercializing products for these customers.

The integration of Ascent's solar modules into space, near space, and aeronautic vehicles with ultra-lightweight and flexible solar modules is an important market opportunity for the Company. Customers in this market have historically required a high level of durability, high voltage and conversion efficiency from solar module suppliers, and we believe our products are well suited to compete in this premium market.

For the three months ended March 31, 2022, we generated $566,210 of total revenue. As of March 31, 2022, we had an accumulated deficit of $432,080,037.

In January 2017, Ascent was awarded a contract to supply high-voltage SuperLight thin-film CIGS PV blankets. These 50W, fully laminated, flexible blankets were manufactured using a new process that was optimized for high performance in near-space conditions at elevated temperatures, and are custom designed for easy modular integration into series and parallel configurations to achieve the desired voltage and current required for such application.

In November 2017, Ascent introduced the next generation of our USB-based portable power systems with the XD™ series. The first product introduced was the XD-12 which, like previous products, is a folding, lightweight, easily stowable, PV system with USB power regulation. Unique to this generation of PV portable power is more PV power (12 Watts) and a 2.0 Amp smart USB output to enable the XD-12 to charge most smartphones, tablets, and USB-enabled devices as fast as a wall outlet. The enhanced smart USB circuit works with the device to be charged so that the device can determine the maximum power it is able to receive from the XD-12 and ensures the best possible charging performance directly from the sun.

Also in 2017, Ascent manufactured a new micro-module for a space customer, approximately 12.8mm x 50mm (0.5in x 2.0in) in size that is ideal for both laboratory-scale environmental testing, and for subsequent integration into flight experiments.

14


Table of Contents

 

In February 2018, the Company introduced the second product in our XD series. Delivering up to 48 Watts of solar power, we believe the durable and compact Ascent XD-48 Solar Charger is the ideal solution for charging many portable electronics and off-grid power systems. The XD-48’s versatility allows it to charge both military and consumer electronics directly from the sun wherever needed. Like the XD-12, the XD-48 has a compact and portable design, and its rugged, weather-resistant construction withstands shocks, drops, damage and even minor punctures to power through the harshest conditions.

In March 2018, we collaborated with a European based customer for their lighter-than-air, helium-filled airship project, which was based on our newly developed ultra-light modules with substrate material that was half of the thickness of our standard modules. In 2019, we completed a repeat order from the same customer who had since established its airship development operation in the US. In 2020, we received a third and enlarged order from the same customer and completed the order in the second quarter of 2021. Most recently, in the 4th quarter of 2021 we received a fourth order with a targeted ship date in the 2nd quarter of 2022.

On September 15, 2021, the Company entered into a Long-Term Supply and Joint Development Agreement (“JDA”) with TubeSolar, a significant existing stakeholder in the Company. See “Principal Stockholders,” and “Certain Transactions.” Under the terms of the JDA, the Company will produce, and TubeSolar will purchase, thin-film PV foils (“PV Foils”) for use in TubeSolar’s solar modules for agricultural photovoltaic (“APV”) applications that require solar foils for its production. Under the JDA, the Company will receive up (i) to $4 million of non-recurring engineering (“NRE”) fees, (ii) up to $13.5 million of payments upon achievement of certain agreed production and cost structure milestones, and (iii) product revenues from sales of PV Foils to TubeSolar. The JDA has no fixed term, and may only be terminated by either party for breach.

The Company and TubeSolar have also jointly established a subsidiary company in Germany, in which TubeSolar holds a minority stake of 30% (the “JV”). The purpose of the JV is to establish and operate a PV manufacturing facility in Germany that will produce and deliver PV Foils exclusively to TubeSolar. Until the JV facility is fully operational, PV Foils will be manufactured in the Company’s existing facility in Thornton, Colorado. The parties expect to jointly develop next generation tooling for use in manufacturing PV Foils at the JV facility. The Company purchased 17,500 shares of the JV for 1 Euro per share, on November 10, 2021.

We continue to design and manufacture PV integrated portable power applications for commercial and military users, including the US Marine Corps, US AF Special Operations Command, US Special Operations Command, US Army Special Operations Command, US Army Futures Command, and others. Due to the high durability enabled by the monolithic integration employed by our technology, the capability to customize modules into different form factors and what we believe is the industry leading light weight and flexibility provided by our modules, we believe that the potential applications for our products are extensive, including anywhere that may need power generation such as in disaster recovery and emergency preparedness, commercial and personal adventure expeditions to remote areas, humanitarian efforts in areas with poor power infrastructure, photography and filming involved in wildlife observation, to name a few.

Commercialization and Manufacturing Strategy

We manufacture our products by affixing a thin CIGS layer to a flexible, plastic substrate using a large format, roll-to-roll process that permits us to fabricate our flexible PV modules in an integrated sequential operation. We use proprietary monolithic integration techniques which enable us to form complete PV modules with little to no back-end assembly cost of inter- cell connections. Traditional PV manufacturers assemble PV modules by bonding or soldering discrete PV cells together. This manufacturing step typically increases manufacturing costs and at times proves detrimental to the overall yield and reliability of the finished product. By reducing or eliminating this added step using our proprietary monolithic integration techniques, we believe we can achieve cost savings in, and increase the reliability of, our PV modules. All tooling necessary for us to meet our near-term production requirements is installed in our Thornton, Colorado plant.

We plan to continue the development of our current PV technology to increase module efficiency, improve our manufacturing tooling and process capabilities and reduce manufacturing costs. We also plan to continue to take advantage of research and development contracts to fund a portion of this development.

15


Table of Contents

 

Significant Trends, Uncertainties and Challenges

We believe the significant trends, uncertainties and challenges that directly or indirectly affect our financial performance and results of operations include:

 

Our ability to generate customer acceptance of and demand for our products;

 

Successful ramping up of commercial production on the equipment installed;

 

The substantial doubt about our ability to continue as a going concern due to our history of operating losses;

 

Successful and timely certification for use in our target markets;

 

Successful operating of production tools to achieve the efficiencies, throughput and yield necessary to reach our cost targets;

 

Salability of the products we design at a price sufficient to generate profits;

 

Our ability to raise sufficient capital to enable us to reach a level of sales sufficient to achieve profitability on terms favorable to us;

 

Effective management of the planned ramp up of our domestic and international operations;

 

Our ability to successfully develop and maintain strategic relationships with key partners, including OEMs, system integrators, distributors, retailers and e-commerce companies, who deal directly with end users in our target markets;

 

Our ability to maintain the listing of our common stock on the OTC Market;

 

Our ability to maintain effective internal controls over financial reporting;

 

Our ability to achieve projected operational performance and cost metrics;

 

Our ability to enter into commercially viable licensing, joint venture, or other commercial arrangements;

 

Availability of raw materials;

 

Potential loss of intellectual property; and

 

COVID-19 and the uncertainty around the continued duration and effect of the worldwide pandemic.

Basis of Presentation: The accompanying unaudited condensed consolidated financial statements have been derived from the accounting records of Ascent Solar Technologies, Inc. and Ascent Solar (Asia) Pte. Ltd. (collectively, the “Company") as of March 31, 2022 and December 31, 2021, and the results of operations for the three months ended March 31, 2022 and 2021. Ascent Solar (Asia) Pte. Ltd. is wholly owned by Ascent Solar Technologies, Inc. All significant inter-company balances and transactions have been eliminated in the accompanying condensed consolidated financial statements.

16


Table of Contents

 

Critical Accounting Policies and Estimates

Critical accounting policies used in reporting our financial results are reviewed by management on a regular basis. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. Processes used to develop these estimates are evaluated on an ongoing basis. Estimates are based on historical experience and various other assumptions that are believed to be reasonable for making judgments about the carrying value of assets and liabilities. Actual results may differ as outcomes from assumptions may change.

The Company’s significant accounting policies were described in Note 3 to the audited financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. There have been no significant changes to our accounting policies as of March 31, 2022.

Results of Operations

 

 

 

Three Months Ended

March 31,

 

 

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

$ Change

 

 

% Change

 

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products

 

$

54,210

 

 

$

165,158

 

 

$

(110,948

)

 

 

-67

%

Milestone and engineering

 

 

512,000

 

 

 

-

 

 

 

512,000

 

 

 

100

%

Total Revenues

 

 

566,210

 

 

 

165,158

 

 

 

401,052

 

 

 

33

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs and Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of Revenue

 

 

532,890

 

 

 

72,782

 

 

 

460,108

 

 

 

632

%

Research, development and

   manufacturing operations

 

 

1,406,322

 

 

 

728,036

 

 

 

678,286

 

 

 

93

%

SG&A

 

 

821,266

 

 

 

561,709

 

 

 

259,557

 

 

 

46

%

Depreciation

 

 

16,665

 

 

 

12,872

 

 

 

3,793

 

 

 

29

%

Total Costs and Expenses

 

 

2,777,143

 

 

 

1,375,399

 

 

 

1,401,744

 

 

 

102

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss From Operations

 

 

(2,210,933

)

 

 

(1,210,241

)

 

 

(1,000,692

)

 

 

83

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income/(Expense)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income/(Expense), net

 

 

-

 

 

 

800

 

 

 

(800

)

 

 

-100

%

Interest Expense

 

 

(2,086,314

)

 

 

(562,079

)

 

 

(1,524,235

)

 

 

271

%

Change in fair value of derivatives and

   gain/(loss) on extinguishment of liabilities

 

 

-

 

 

 

3,617,904

 

 

 

(3,617,904

)

 

 

-100

%

Income/(Loss) on Equity Method Investments

 

 

(2

)

 

 

 

 

 

 

(2

)

 

 

100

%

Total Other Income/(Expense)

 

 

(2,086,316

)

 

 

3,056,625

 

 

 

(5,142,941

)

 

 

-168

%

Net (Loss)/Income

 

$

(4,297,249

)

 

$

1,846,384

 

 

$

(6,143,633

)

 

 

-333

%

Comparison of the Three Months Ended March 31, 2022 and 2021

Total Revenues. Our total revenues increased by $401,052, or 33%, for the three months ended March 31, 2022 when compared to the same period in 2021, due primarily to the NRE fees received from TubeSolar in the current period. This was partially offset by lower product revenue in the current period.

Cost of revenues. Cost of revenues is primarily comprised of repair and maintenance, direct labor, and overhead expenses. Our Cost of revenues increased by $460,108, or 632%, for the three months ended March 31, 2022 when compared to the same period in 2021. This is due primarily to the increase in repair and maintenance, personnel, and other operating costs as a result of an increase in operations during the three months ended March 31, 2022 when compared to the same period in 2021. Management believes our factory is significantly under-utilized, and a substantial increase in revenue would result in marginal

17


Table of Contents

 

increases to Direct Labor and Overhead included in the Cost of revenues. As such management’s continued focus going forward is to improve gross margin through increased sales and improved utilization of our factory.

Research, development and manufacturing operations. Research, development and manufacturing operations costs include costs incurred for product development, pre-production and production activities in our manufacturing facility. Research, development and manufacturing operations costs also include costs related to technology development. Research, development and manufacturing operations costs increased by $678,286, or 93%, for the three months ended March 31, 2022 when compared to the same period in 2021. This is due primarily to an increase in repair and maintenance, personnel and other operating costs as a result of increased level of operations in the current period as compared to the Company’s restart status in the same period in 2021.

Selling, general and administrative. Selling, general and administrative expenses increased by $259,557, or 46%, for the three months ended March 31, 2022 when compared to the same period in 2021. The increase in costs is due primarily to increased personnel and personnel related costs in the current period as compared to the Company’s restart status in the same period in 2021.

Other Income/Expense. Other income decreased $5,142,941, or 168%, for the three months ended March 31, 2022 when compared to the same period in 2021. The decrease is due primarily to a gain from the change in fair value of derivative liabilities recognized in the prior period compared to the current period where the Company accelerated the amortization of approximately $2 million in convertible debt discount and recognized it as interest expense as the convertible debt holders converted their debt.   

Net (Loss)/Income. Our Net Loss increased by $6,143,633, or 333%, for the three months ended March 31, 2022 compared to the same period in 2021 primarily due to the items mentioned above.

 

Liquidity and Capital Resources

The Company has continued limited PV production at its manufacturing facility. The Company does not expect that sales revenue and cash flows will be sufficient to support operations and cash requirements until it has fully implemented its product strategy. During the three months ended March 31, 2022 the Company used $2,792,080 in cash for operations.

Additional projected total revenues are not anticipated to result in a positive cash flow position for the year overall and, as of March 31, 2022, the Company has working capital of $1,439,461. As such, cash liquidity would not be sufficient for the next twelve months and will require additional financing.

The Company continues to accelerate sales and marketing efforts related to its military solar products and specialty PV application strategies through expansion of its sales and distribution channels. The Company has begun activities related to securing additional financing through strategic or financial investors, but there is no assurance the Company will be able to raise additional capital on acceptable terms or at all. If the Company's revenues do not increase rapidly, and/or additional financing is not obtained, the Company will be required to significantly curtail operations to reduce costs and/or sell assets. Such actions would likely have an adverse impact on the Company's future operations.

As a result of the Company’s recurring losses from operations, and the need for additional financing to fund its operating and capital requirements, there is uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises doubt as to the Company’s ability to continue as a going concern.

Management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. These condensed consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.

18


Table of Contents

 

Statements of Cash Flows Comparison of the Three Months Ended March 31, 2022 and 2021

For the three months ended March 31, 2022, our cash used in operations was $2,792,080 compared to $2,009,294 for the three months ended March 31, 2021, an increase of $782,786. The increase is due primarily to the scaling up of operations during the current period as compared to the Company’s restart status in the 2021 three months period. For the three months ended March 31, 2022, cash used in investing activities was $141,318 compared to no cash provided by investing activities for the three months ended March 31, 2021. This change was due primarily to the Company investing in new PP&E in the current period. During the three months ended March 31, 2022, net cash used in operations of $2,792,080 were funded through the proceeds from issuances of preferred and common stock during 2021.

Off Balance Sheet Transactions

As of March 31, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

Smaller Reporting Company Status

We are a “smaller reporting company” meaning that the market value of our stock held by non-affiliates is less than $700 million and our annual revenue was less than $100 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700 million. As a smaller reporting company, we may rely on exemptions from certain disclosure requirement that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and smaller reporting companies have reduced disclosure obligations regarding executive compensation.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Foreign Currency Exchange Risk

We hold no significant funds and have no significant future obligations denominated in foreign currencies as of March 31, 2022.

Although our reporting currency is the U.S. Dollar, we may conduct business and incur costs in the local currencies of other countries in which we may operate, make sales and buy materials. As a result, we are subject to currency translation risk. Further, changes in exchange rates between foreign currencies and the U.S. Dollar could affect our future net sales and cost of sales and could result in exchange losses.

Interest Rate Risk

Our exposure to market risks for changes in interest rates relates primarily to our cash equivalents and investment portfolio. As of March 31, 2022, our cash equivalents consisted only of operating accounts held with financial institutions. From time to time, we may hold restricted funds, money market funds, investments in U.S. government securities and high-quality corporate securities. The primary objective of our investment activities is to preserve principal and provide liquidity on demand, while at the same time maximizing the income we receive from our investments without significantly increasing risk. The direct risk to us associated with fluctuating interest rates is limited to our investment portfolio, and we do not believe a change in interest rates will have a significant impact on our financial position, results of operations, or cash flows.

Item 4.  Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms. Our disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosures. Our management conducted an evaluation required by

19


Table of Contents

 

Rules 13a-15 and 15d-15 under the Exchange Act of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15 and 15d-15 under the Exchange Act as of March 31, 2022. Based on this evaluation, our management concluded the design and operation of our disclosure controls and procedures were effective as of March 31, 2022.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our system of internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles ("U.S. GAAP") in the United States of America and includes those policies and procedures that:

 

pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

 

provide reasonable assurance transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

 

provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

Under the supervision of the Audit Committee of the Board of Directors and with the participation of our management, including our Chief Executive Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting using the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this evaluation, our management concluded our internal controls over financial reporting were effective as of March 31, 2022. Our management reviewed the results of its assessment with the Audit Committee.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 Changes in Internal Control Over Financial Reporting

There were no other changes in internal control over financial reporting during the three months ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

20


Table of Contents

 

PART II. OTHER INFORMATION

From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. We are not currently aware of any such proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations.

Item 1A. Risk Factors

The COVID-19 pandemic in the United States and world-wide has caused business disruption which may negatively impact the Company’s operations and results. While the disruption is currently expected to be temporary, there is considerable uncertainty around the duration. It is therefore likely there will be an impact on the Company’s operating activities and results. However, the related financial impact and duration cannot be reasonably estimated at this time.

In addition to the information set forth in this Form 10-Q, you should carefully consider the risk factors disclosed under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021. There have been no material changes to our risk factors from those included in our Annual Report on Form 10-K for the year ended December 31, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Use of Proceeds

Not applicable.

Issuer Purchases of Equity Securities

We did not repurchase any of our equity securities during the three months ended March 31, 2022.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

21


Table of Contents

 

Item 6. Exhibits

The exhibits listed on the accompanying Index to Exhibits on this Form 10-Q are filed or incorporated into this Form 10-Q by reference.

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

    3.1

 

Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.2 to our Registration Statement on Form SB-2 filed on January 23, 2006 (Reg. No. 333-131216))

 

 

 

    3.2

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2011)

 

 

 

    3.3

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed February 11, 2014)

 

 

 

    3.4

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company, dated August 26, 2014. (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed September 2, 2014)

 

 

 

    3.5

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company, dated October 27, 2014 (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K dated October 28, 2014)

 

 

 

    3.6

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company, dated December 22, 2014. (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K dated December 23, 2014)

 

 

 

    3.7

 

Second Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to our Current Report on Form 8-K filed on February 17, 2009)

 

 

 

    3.8

 

First Amendment to Second Amended and Restated Bylaws (incorporated by reference to Exhibit 3.3 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2009)

 

 

 

    3.9

 

Second Amendment to Second Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed January 25, 2013)

 

 

 

    3.10

 

Third Amendment to Second Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed December 18, 2015)

 

 

 

    3.11

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company, dated May 26, 2016 (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed June 2, 2016)

 

 

 

    3.12

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company, dated September 15, 2016 (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed September 16, 2016)

 

 

 

    3.13

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company, dated March 16, 2017 (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed March 17, 2017)

 

 

 

    3.14

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company, dated July 19, 2018 (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed July 23, 2018)

 

 

 

    3.15

 

Certificate of Designations of Preferences, Rights, and Limitations of Series 1A Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed September 30, 2020)

 

 

 

    3.16

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company, dated September 23, 2021 (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed September 24, 2021)

22


Table of Contents

 

 

 

 

    3.17

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company, dated January 27, 2022 (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed February 2, 2022)

 

 

 

    4.1

 

Form of Common Stock Certificate (incorporated by reference to Exhibit 4.1 to our Registration Statement on Form SB-2/A filed on June 6, 2006 (Reg. No. 333-131216))

 

 

 

    4.2

 

Certificate of Designations of Series A Preferred Stock (filed as Exhibit 4.2 to our Registration Statement on Form S-3 filed July 1, 2013 (Reg. No. 333-189739))

 

 

 

    4.3

 

Description of Securities (incorporated by reference to Exhibit 4.3 to our Annual Report on Form 10-K filed May 13, 2021)

 

 

 

  10.1 CTR

 

Securities Purchase Agreement, dated January 17, 2006, between the Company and ITN Energy Systems, Inc. (incorporated by reference to Exhibit 10.1 to our Registration Statement on Form SB-2 filed on January 23, 2006 (Reg. No. 333-131216))

 

 

 

  10.2 CTR

 

Invention and Trade Secret Assignment Agreement, dated January 17, 2006, between the Company and ITN Energy Systems, Inc. (incorporated by reference to Exhibit 10.2 to our Registration Statement on Form SB-2 filed on January 23, 2006 (Reg. No. 333-131216))

 

 

 

  10.3

 

Patent Application Assignment Agreement, dated January 17, 2006, between the Company and ITN Energy Systems, Inc. (incorporated by reference to Exhibit 10.3 to our Registration Statement on Form SB-2 filed on January 23, 2006 (Reg. No. 333-131216))

 

 

 

  10.4 CTR

 

License Agreement, dated January 17, 2006, between the Company and ITN Energy Systems, Inc. (incorporated by reference to Exhibit 10.4 to our Registration Statement on Form SB-2 filed on January 23, 2006 (Reg. No. 333-131216))

 

 

 

  10.5

 

Letter Agreement, dated November 23, 2005, among the Company, ITN Energy Systems, Inc. and the University of Delaware (incorporated by reference to Exhibit 10.16 to our Registration Statement on Form SB-2/A filed on May 26, 2006 (Reg. No. 333-131216))

 

 

 

  10.6 CTR

 

License Agreement, dated November 21, 2006, between the Company and UD Technology Corporation (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on November 29, 2006)

 

 

 

  10.7

 

Novation Agreement, dated January 1, 2007, among the Company, ITN Energy Systems, Inc. and the United States Government (incorporated by reference to Exhibit 10.23 to our Annual Report on Form 10-KSB for the year ended December 31, 2006)

 

 

 

  10.8

 

Executive Employment Agreement, dated April 4, 2014, between the Company and Victor Lee (filed as Exhibit 10.1 to our Current Report on Form 8-K filed on April 9, 2014)

 

 

 

  10.9

 

Seventh Amended and Restated 2005 Stock Option Plan (incorporated by reference to Annex B of our definitive proxy statement dated April 22, 2016)

 

 

 

  10.10

 

Seventh Amended and Restated 2008 Restricted Stock Plan Stock Option Plan Plan (incorporated by reference to Annex A of our definitive proxy statement dated April 22, 2016)

 

 

 

  10.11+

 

Industrial Lease for 12300 Grant Street, Thornton, Colorado dated September 21, 2020 (incorporated by reference to Exhibit 10.50 to our Annual Report on Form 10-K filed January 29, 2021)

 

 

 

  10.12+

 

Long-Term Supply and Joint Development Agreement dated September 15, 2021 (incorporated by reference to Exhibit 10.2 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2021)

 

 

 

  10.13

 

Fleur Capital Unsecured Convertible Promissory Note dated January 3, 2022

 

 

 

  10.14

 

Nanyang Unsecured Convertible Promissory Note dated January 21, 2022

 

 

 

  31.1*

 

Chief Executive Officer Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

  31.2*

 

Chief Financial Officer Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

  32.1*

 

Chief Executive Officer Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

  32.2*

 

Chief Financial Officer Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

23


Table of Contents

 

101.INS

 

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

*

 

Filed herewith

 

 

 

CTR

 

Portions of this exhibit have been omitted pursuant to a request for confidential treatment.

 

 

 

 

Denotes management contract or compensatory plan or arrangement.

 

 

 

+

 

Certain portions of the exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K. The omitted information is (i) not material and (ii) would likely cause competitive harm to the Company if publicly disclosed.

 

24


Table of Contents

 

 

ASCENT SOLAR TECHNOLOGIES, INC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the 12th day of May, 2022.

 

 

ASCENT SOLAR TECHNOLOGIES, INC.

 

 

 

May 12, 2022

By:

/s/ VICTOR LEE

 

 

Lee Kong Hian (aka Victor Lee)

President and Chief Executive Officer

(Principal Executive Officer)

 

 

 

May 12, 2022

By:

/s/ MICHAEL J. GILBRETH

 

 

Michael J. Gilbreth

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

25

Ascent Solar Technologies (PK) (USOTC:ASTI)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Ascent Solar Technologies (PK) Charts.
Ascent Solar Technologies (PK) (USOTC:ASTI)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Ascent Solar Technologies (PK) Charts.